Lificiguat
CAS No. 170632-47-0
Lificiguat ( YC1; YC 1; YC-1; Lificiguat )
Catalog No. M18115 CAS No. 170632-47-0
YC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 39 | In Stock |
|
10MG | 55 | In Stock |
|
25MG | 114 | In Stock |
|
50MG | 227 | In Stock |
|
100MG | 389 | In Stock |
|
200MG | 575 | In Stock |
|
500MG | 888 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLificiguat
-
NoteResearch use only, not for human use.
-
Brief DescriptionYC-1 is an nitric oxide (NO)-independent activator of soluble guanylyl cyclase(sGC) and an inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha).
-
DescriptionLificiguat, also known as YC-1, is a inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha). YC-1 is widely used as a potent inhibitor of HIF-1alpha both in vitro and in vivo, and is also being developed as a novel anticancer drug. YC-1 effectively inhibits tumor invasion and metastasis, and imply that YC-1 is worth while to further develop as a multipurpose anticancer drug.
-
SynonymsYC1; YC 1; YC-1; Lificiguat
-
PathwayOthers
-
TargetOther Targets
-
RecptorsGC;HIF-1α
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number170632-47-0
-
Formula Weight304.34
-
Molecular FormulaC19H16N2O2
-
Purity98%
-
SolubilityDMSO : ≥ 51 mg/mL; 167.58 mM
-
SMILESOCC1=CC=C(C2=NN(CC3=CC=CC=C3)C4=C2C=CC=C4)O1
-
Chemical Name5-[1-(phenylmethyl)-1H-indazol-3-yl]-2-furanmethanol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Martin E,etal.YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12938-42.
molnova catalog
related products
-
L-Threonic acid magn...
L-Threonic acid magnesium salt (L-TAMS) increases synapse density and memory ability in both aged rats and late stage Alzheimer’s disease (AD) model mice.
-
Corticotropin-releas...
Corticotropin-releasing factor human (Human CRF; Human corticotropin-releasing factor) is an immunomodulatory neuropeptide that acts to release ACTH from the anterior pituitary and stimulates the sympathetic nervous system and adrenal medulla. Functions by reducing hyperpolarizations. Acts as a functional antagonist of inflammatory mediators.
-
HCGRP-(8-37)
Rat CGRP-(8-37) (VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF) is a highly selective CGRP receptor antagonist